HOME ·

GIANT BIOGENE

GIANT BIOGENE(02367.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 939.71 million, YoY decrease of 20.5%
Tags：
GIANT BIOGENE02367.HKProfit declined
2026-08-19
GIANT BIOGENE(02367.HK): Cross-linked Recombinant Collagen Implant Obtains NMPA Medical Device Registration Certificate, World’s First Filler Indicated for Neck Wrinkle Correction
Tags：
GIANT BIOGENE02367.HKMedical Device Registration Certificate
2026-06-17
GIANT BIOGENE(02367.HK) closed 7.89% higher, The full-day turnover stood at HKD 541.86 million
Tags：
GIANT BIOGENE02367.HK
2026-04-21
GIANT BIOGENE(02367.HK) will spend HKD 13.76 million to repurchase 400 thousand shares on Jan 9, 2026
Tags：
GIANT BIOGENE02367.HK
2026-01-09